The Australasian Myeloma Research Consortium (AMaRC) in collaboration with theAustralasian Leukaemia & Lymphoma Group (ALLG) and the Myeloma and...
Myeloma NZ
Consensus statement on the treatment of transplant eligible patients with newly diagnosed multiple myeloma in New Zealand
The New Zealand Myeloma Interest Group is comprised of representative haematologists from District Health Boards around the country with a special...
Dr Ken Romeril, Multiple Myeloma founder, Member of the NZ Order of Merit, advocates for the desperate need for access to modern medicines for myeloma sufferers.
https://www.stuff.co.nz/opinion/300759926/miracle-medicines-a-cancer-specialist-sends-a-message-to-pharmac
Multiple Myeloma Summit 2022
Myeloma experts convened in person and online for the 2022 Multiple Myeloma Queenstown Summit, hosted by Myeloma New Zealand. This year’s meeting...
Multiple Myeloma NZ campaigns for Pharmac to fund medicine
Myeloma New Zealand has started a campaign to press Pharmac into funding a treatment that has been standard-of-care throughout the Organisation for...
BLOOD CANCER PATIENTS IMPLORE PHARMAC TO FUND DESPERATELY NEEDED MEDICINE
MEDIA RELEASE 7 September 2022 New Zealanders living with multiple myeloma, a deadly, relapsing/remitting blood cancer, are mounting a major,...
Multiple Myeloma Research Review
Multiple_Myeloma_Research_Review_Issue_43Download
Newsletter: Winter 2022
I hope that you are all keeping as well as possible with all these viruses circulating at the moment. I see from some comments on the Facebook page...
Rachel Smalley: 1,000 kiwis will die while Pharmac takes eight months to make a decision
OPINION: How long does it take you to make a decision about whether or not to buy something? You’ve got all the information in front of you. You...
Multiple Myeloma Queenstown Summit
In August 2022, Myeloma New Zealand is hosting its 4th Myeloma Summit for medical professionals in Queenstown. Held in 2016,2018, 2020 and now again...
Multiple Myeloma Research Review
Multiple_Myeloma_Research_Review_Issue_42Download
Multiple Myeloma CEO, Dr Ken Romeril, on The AM Show this morning, calling for a release of the independent report on Pharmac
Please click on this link to watch the interview: https://fb.watch/cWyMuvV_QO/